{"title":"Complicated Persistent Peritonitis","authors":"B. Roth, K. Sarkar","doi":"10.29046/tmf.020.1.009","DOIUrl":null,"url":null,"abstract":"Spontaneous bacterial peritonitis (SBP) is a common complication of end-stage liver disease. SBP can present with many symptoms such as abdominal pain, fever and altered mental status. The diagnosis of SBP is made when ascitic fluid from a paracentesis has an absolute neutrophil count (ANC) more than 250/uL, there is a positive ascitic fluid culture, and no secondary source of infection can be idenitifed. However, nearly 60% of patients with SBP have negative fluid cultures. These patients can still potentially have SBP and should be treated as such since in-hospital mortality ranges from 20-40%. Conventional treatment for SBP includes a third-generation cephalosporin for five days, followed by lifetime prophylaxis most commonly with a fluoroquinolone. After 48 hours of antibiotic treatment, a repeat paracentesis should be performed. If the ANC does not decrease by at least 25%, it is considered a therapeutic failure and the antibiotic should be changed. With early diagnosis and appropriate antibiotic regimen, SBP is treatable.","PeriodicalId":246494,"journal":{"name":"The Medicine Forum","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Medicine Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29046/tmf.020.1.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Spontaneous bacterial peritonitis (SBP) is a common complication of end-stage liver disease. SBP can present with many symptoms such as abdominal pain, fever and altered mental status. The diagnosis of SBP is made when ascitic fluid from a paracentesis has an absolute neutrophil count (ANC) more than 250/uL, there is a positive ascitic fluid culture, and no secondary source of infection can be idenitifed. However, nearly 60% of patients with SBP have negative fluid cultures. These patients can still potentially have SBP and should be treated as such since in-hospital mortality ranges from 20-40%. Conventional treatment for SBP includes a third-generation cephalosporin for five days, followed by lifetime prophylaxis most commonly with a fluoroquinolone. After 48 hours of antibiotic treatment, a repeat paracentesis should be performed. If the ANC does not decrease by at least 25%, it is considered a therapeutic failure and the antibiotic should be changed. With early diagnosis and appropriate antibiotic regimen, SBP is treatable.